Specifically, in vitro and in vivo experimental results showed that PLEKHA7 was gradually lost during tumour progression to malignancy in GC and that PLEKHA7 deficiency exacerbated tumour invasion and metastasis. The gene discussed is PLEKHA7; the disease is gastric cancer.